GlobeNewswire

Synthesio Acquired By Ipsos, Reinforcing Social Media Intelligence Capabilities

Del

Enhancing customers’ understanding of online conversations and enabling the transformation of social data into strategic business insights

NEW YORK, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Synthesio, the company behind the leading global Social Media Intelligence Suite, is pleased to announce that it has been acquired by Ipsos. Founded in 1975, Ipsos is the market research and opinion leader, headquartered in Paris, with over 16,000 employees and a presence in 89 countries.

“We are very excited to join the Ipsos family and write the next chapters of the Synthesio story,” said Loic Moisand, CEO & Co-Founder of Synthesio. “Our focus on innovative technology including Artificial Intelligence, to detect consumer insights from billions of online conversations coupled with Ipsos’ decades of market research & consulting experience, will give our joint customers a single path for building and advancing their social intelligence programs. This acquisition will lead customers to more actionable and real-time social insights, fused with AI, and give them a stronger competitive advantage in the market.”

Used by hundreds of global enterprises, Synthesio's Social Listening Platform was recently named a Leader in the Forrester Wave™: Social Listening Platforms, Q3 2018 report. The report notes the company vision saying that “Synthesio anticipates a convergence among marketing, communication, and customer experience disciplines.” This comment is based on Synthesio's product roadmap, which is focused on providing a wide array of solutions to many business units across an enterprise. Upcoming product releases are focused on fast and powerful dashboard setup, influencer marketing, trend analysis, Artificial Intelligence, and more.

“The acquisition of Synthesio is part of the Total Understanding Project and its targeted acquisition objectives,” commented Didier Truchot, Ipsos Chairman & CEO. “It will reinforce Ipsos’ technologies and know-how in social listening and the monitoring of the data that comes with it. We are happy to welcome Synthesio’s leadership team onboard. By combining our strengths, we will grant our clients access to a wider range of data, actionable insights and a deeper understanding of customers."

Beyond product innovation, Synthesio plans to grow its international presence and services beyond its existing five offices. Synthesio will be a standalone business unit at Ipsos, maintaining the name and brand. Loic Moisand, and the Synthesio leadership team, will continue to drive the company on this exciting new stage of investment and growth.

For more details, please go to synthesio.com/ipsos.

About Synthesio
Synthesio, an Ipsos company, is a global Leader in the latest report on Social Listening Platforms published by an independent research firm. Synthesio provides brands and agencies around the world with social listening tools and audience insights to measure the impact of social and mainstream media conversations. The Synthesio Social Media Intelligence Suite surfaces actionable insights — both qualitative and quantitative — from the most extensive collection of data on the market. Business units can leverage Synthesio dashboards, pre-built use cases, customizable reports, and social media command center displays — coupled with Ipsos’ social intelligence solutions — to make strategic business decisions. Synthesio was founded in 2006 and has offices in New York, Paris, London, Singapore, and Brussels.

Media Contact:

Adam Dalezman
Senior Communications Manager
adalezman@synthesio.com

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Tenaris to Acquire IPSCO Tubulars from TMK22.3.2019 13:58:00 CETPressemelding

LUXEMBOURG, March 22, 2019 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE, Buenos Aires and Mexico: TS and MTA Italy: TEN) announced today that it has entered into a definitive agreement to acquire from PAO TMK, a Russian company and manufacturer of steel pipe, 100% of the shares of its wholly owned U.S. subsidiary IPSCO Tubulars, Inc., for US$1,209 million, on a cash-free, debt-free basis, which includes US$270 million of working capital. The transaction is subject to regulatory approvals, including approval by the U.S. antitrust authorities, and other customary conditions. IPSCO Tubulars is a U.S. domestic producer of seamless and welded OCTG and line pipe products, with an annual production capacity of 450,000 metric tons of steel bars, 400,000 metric tons of seamless pipe and 1,000,000 metric tons of welded pipe, and production facilities spread throughout the country. The acquisition would enhance Tenaris’s position and local manufacturing presence in the U.S. market, extending its produc

Oxford Immunotec Announces Chief Financial Officer Transition21.3.2019 21:01:00 CETPressemelding

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that Richard Altieri, the Company’s Chief Financial Officer (CFO), will retire on April 30, 2019. The Company has appointed Matthew McLaughlin, currently Chief Financial Officer, GE Healthcare – U.S. and Canada, as his successor. Mr. McLaughlin will join Oxford Immunotec as CFO on April 8, 2019. Today’s announcement concludes an extensive search process conducted by the Company. As part of the planned succession, Mr. Altieri, who has led Oxford Immunotec’s global finance organization as CFO since 2012, will remain an active member of the Company’s management team until his retirement date. “During his seven year tenure, Rick successfully managed multiple financing rounds, including the Company's IPO, the acquisition and financial integration of three companies and, most recently, the dives

Blackhawks, Flyers, Sabres and Lightning Headline the 2019 NHL Global Series21.3.2019 15:34:00 CETPressemelding

Chicago Blackhawks and Philadelphia Flyers to Open Regular Season in Prague, Czech Republic on Oct. 4 Buffalo Sabres and Tampa Bay Lightning to Face Off in a Pair of Games in Stockholm, Sweden on Nov. 8 and Nov. 9 2019 NHL Global Series Challenge to feature Blackhawks vs. Eisbären Berlin on Sept. 29 in Berlin, Germany and Flyers vs. Lausanne HC on Sept. 30 in Lausanne, Switzerland Tickets to Games in Berlin, Prague and Stockholm Available for Purchase on Wednesday, March 27; Tickets to Game in Lausanne Available for Purchase on Wednesday, April 10 NEW YORK/TORONTO, March 21, 2019 (GLOBE NEWSWIRE) -- The National Hockey League (NHL) and the National Hockey League Players’ Association (NHLPA), in conjunction with Live Nation Sweden, today announced that the Buffalo Sabres, Chicago Blackhawks, Philadelphia Flyers and Tampa Bay Lightning will participate in the 2019 NHL Global Series. The Chicago Blackhawks and Philadelphia Flyers will play their 2019-20 season-opening game against each ot

Farmako: World's Largest Import Contract for Pharmaceutical Cannabis21.3.2019 15:10:00 CETPressemelding

German Farmako secures 50 tonnes of flowers and oils from Polish company Pharmacann Polska FRANKFURT, March 21, 2019 (GLOBE NEWSWIRE) -- Farmako will import 50 tonnes of pharmaceutical cannabis from Pharmacann Polska into the European market over the next four years. This provides the basis for a reliable supply of pharmaceutical cannabis for millions of patients in the European healthcare system. The company expects a total revenue of several hundred million Euros from the agreed exclusive partnership. Founded in September 2018, Farmako now has grown to 40 employees and is distributing high-quality pharmaceutical cannabis to German pharmacies since March 2019. This is the biggest Cannabis contract to date, and the first big contract without participation of a Canadian LP. Farmako has signed an exclusive and binding agreement to import and distribute 50 tons of pharmaceutical cannabis over four years. Farmako and Pharmacann Polska enter strategic partnership to develop custom tailored

NexOptic Appoints Rich Geruson, Former Lexmark CEO, to Board of Directors21.3.2019 14:00:00 CETPressemelding

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- NexOptic Technology Corp. ("NexOptic" or the "Company") (TSX VENTURE: NXO) (OTCQX: NXOPF) (FRANKFURT: E3O1) is pleased to announce that Richard J. (Rich) Geruson has joined its Board of Directors, effective immediately. Mr. Geruson’s experience spans CEO roles at Lexmark International, Phoenix Technologies and VoiceSignal Technologies, and Senior Vice President and executive positions at Nokia, IBM, Toshiba, and McKinsey & Co. As CEO of Lexmark International, a multibillion-dollar imaging technology and solutions company with 10,000 employees, he grew printer sales faster than at any time in the preceding 10 years while simultaneously executing extensive process reengineering, transforming the business from negative EBITDA and high debt to positive multi-hundred-million-dollar EBITDA and a healthy debt profile. While CEO of Phoenix Technologies, he achieved consistently high profit year-over-year for six years straight in